Solid Biosciences Inc (SLDB)
9.12
+0.17
(+1.90%)
USD |
NASDAQ |
May 20, 16:00
9.12
0.00 (0.00%)
After-Hours: 20:00
Solid Biosciences Cash from Investing (Quarterly): -38.49M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -38.49M |
December 31, 2023 | 45.30M |
September 30, 2023 | -24.64M |
June 30, 2023 | -48.23M |
March 31, 2023 | 37.26M |
December 31, 2022 | 66.10M |
September 30, 2022 | 14.91M |
June 30, 2022 | -59.60M |
March 31, 2022 | 37.74M |
December 31, 2021 | 30.18M |
September 30, 2021 | -72.51M |
June 30, 2021 | -48.72M |
March 31, 2021 | -0.035M |
December 31, 2020 | -0.06M |
September 30, 2020 | -0.08M |
Date | Value |
---|---|
June 30, 2020 | 0.322M |
March 31, 2020 | 6.418M |
December 31, 2019 | 2.855M |
September 30, 2019 | 3.963M |
June 30, 2019 | 24.14M |
March 31, 2019 | -6.445M |
December 31, 2018 | -21.26M |
September 30, 2018 | -1.397M |
June 30, 2018 | -2.49M |
March 31, 2018 | -1.611M |
December 31, 2017 | -2.809M |
September 30, 2017 | -7.316M |
June 30, 2017 | 13.61M |
March 31, 2017 | 6.962M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-72.51M
Minimum
Sep 2021
66.10M
Maximum
Dec 2022
-1.158M
Average
1.588M
Median
Cash from Investing (Quarterly) Benchmarks
Sarepta Therapeutics Inc | 218.80M |
PTC Therapeutics Inc | -114.93M |
Capricor Therapeutics Inc | -9.502M |
Catalyst Pharmaceuticals Inc | -0.199M |
Pfizer Inc | 1.732B |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -25.19M |
Cash from Financing (Quarterly) | 107.24M |
Free Cash Flow | -92.54M |
Free Cash Flow Per Share (Quarterly) | -0.6642 |
Free Cash Flow Yield | -41.37% |